Haemophilia affects nearly 850,000 people worldwide, with India having the second-largest population of patients. Pro. (Dr) Prakas Kumar Mandal highlighted that early prophylaxis, regular Factor VIII replacement, prevents life-threatening bleeds, joint damage, and disability. Shifting from on-demand treatment to prophylaxis improves quality of life and long-term outcomes, especially in children.